SUNWELS Co.,Ltd. AI Stock Analysis
Want to see JP:9229 full AI Analyst Report?
SUNWELS Co.,Ltd. (9229) AI Stock Analysis
SUNWELS Co.,Ltd.
(TSE/TYO:9229)
The company faces severe financial distress with negative earnings, cash flow, and high leverage, which are the primary drivers of the low score. Technicals confirm a persistent downtrend, and the negative P/E ratio offers no valuation support. The overall risk profile is extremely high.
SUNWELS Co.,Ltd. (9229) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.41B
- Dividend Yield
- ―
- Average Volume (3M)
- 276.62K
- Price to Earnings (P/E)
- -2.5
- Beta (1Y)
- 1.05
- Revenue Growth
- 7.75%
- EPS Growth
- 49.71%
- Country
- Japan
- Employees
- 3,570
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
SUNWELS Co.,Ltd. Business Overview & Revenue Model
Company Description
Sunwels Co., Ltd. primarily delivers nursing care services, with its operations prominently featuring the "PD house" model. The company runs specialized residential facilities for seniors diagnosed with Parkinson's disease and also manages a Kaatsu t...
How the Company Makes Money
SUNWELS generates revenue primarily by operating care and welfare services and charging fees associated with those services. Key revenue streams are expected to include (1) service fees from providing nursing care/welfare services (often structured a...
SUNWELS Co.,Ltd. Financial Statement Overview
Summary
Revenue growth is strong, but profitability has collapsed with negative margins and net losses. The balance sheet is highly leveraged (D/E 4.2x) with negative ROE, and operating cash flow has turned negative, raising severe liquidity and solvency concerns.
Income Statement
25NegativeBalance Sheet
20Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.83B | 28.14B | 26.50B | 20.11B | 13.24B | 8.17B |
| Gross Profit | 2.74B | 2.76B | 4.89B | 5.13B | 3.24B | 1.60B |
| EBITDA | 2.01B | 1.88B | 1.88B | 3.15B | 1.52B | 573.94M |
| Net Income | -1.49B | -1.66B | -925.00M | 802.00M | 303.60M | 10.65M |
Balance Sheet | ||||||
| Total Assets | 45.05B | 45.63B | 39.44B | 31.74B | 19.30B | 9.10B |
| Cash, Cash Equivalents and Short-Term Investments | 3.93B | 4.09B | 5.64B | 3.31B | 2.61B | 814.76M |
| Total Debt | 29.03B | 29.11B | 22.49B | 20.11B | 11.20B | 6.60B |
| Total Liabilities | 38.63B | 38.66B | 30.82B | 26.54B | 14.69B | 8.52B |
| Stockholders Equity | 6.42B | 6.97B | 8.62B | 5.20B | 4.61B | 580.80M |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.50B | -2.32B | -2.93B | -740.86M | -73.95M |
| Operating Cash Flow | 0 | -332.00M | 1.88B | 2.56B | 1.14B | 378.19M |
| Investing Cash Flow | 0 | -1.27B | -4.40B | -5.66B | -2.04B | -633.05M |
| Financing Cash Flow | 0 | 62.00M | 4.84B | 3.80B | 2.70B | 573.26M |
SUNWELS Co.,Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Negative. The current price of 105.00 is below the 20-day moving average (MA) of 111.60, below the 50-day MA of 112.22, and below the 200-day MA of 175.08, indicating a bearish trend. The MACD of -1.43 indicates Positive momentum. The RSI at 39.83 is Neutral, neither overbought nor oversold. The STOCH value of 61.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9229.
SUNWELS Co.,Ltd. Peers Comparison
Overall Rating
JP:922069.75Neutral
JP:237356Neutral
JP:242555Neutral
JP:706149Neutral
JP:922938Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Neutral | JPY 3.01B | 6.33 | ― | 3.52% | 5.71% | 10.34% | |
| 56Neutral | JPY 5.18B | 17.93 | ― | 4.46% | 4.76% | -52.55% | |
| 55Neutral | JPY 2.50B | 27.76 | ― | 3.42% | -3.64% | -66.52% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | JPY 3.03B | -28.15 | ― | ― | 6.75% | -119.69% | |
| 38Underperform | JPY 3.87B | -2.52 | ― | ― | 7.75% | 49.71% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:9229 | SUNWELS Co.,Ltd. | 105.00 | -343.00 | -76.56% | |
| JP:2373 | Care Twentyone Corporation | 381.00 | -54.94 | -12.60% | |
| JP:2425 | Care Service Co., Ltd. | 643.00 | -130.78 | -16.90% | |
| JP:7061 | Japan Hospice Holdings Inc. | 337.00 | -944.94 | -73.71% | |
| JP:9220 | FB CARE SERVICE CO.,LTD. | 1222.00 | 24.07 | 2.01% |
SUNWELS Co.,Ltd. Corporate Events
SUNWELS books extraordinary loss as voluntary retirement program trims care workforce
SUNWELS Co., Ltd. has completed a voluntary retirement program targeting non-managerial care, nursing and rehabilitation staff in designated areas, after receiving 231 applications and approving 112 employees to leave by October 31, 2026. Management...
SUNWELS Extends Loan Principal Deferral to Support Structural Reforms
SUNWELS Co., Ltd. has secured agreements with nine financial institutions to extend the deferral of principal repayments on its existing borrowings, pushing back payments originally due between October 1, 2026 and March 31, 2027. The deferral covers...
SUNWELS Launches Voluntary Retirement Program to Streamline Care Operations
SUNWELS Co., Ltd. has approved a voluntary retirement program as part of a broader effort to optimize personnel allocation in response to shifts in its earnings structure, including recent revisions to medical service fees. The initiative targets non...
Sunwels Names Former Health Ministry Official as President to Rebuild Trust
Sunwels Co., Ltd. has appointed Toshihiko Atarashi as President and Representative Director, signaling a leadership shift aimed at restoring trust and strengthening governance. Atarashi brings extensive experience from the Ministry of Health, Labour...
SUNWELS Narrows Quarterly Losses on Higher Sales but Keeps Zero-Dividend Outlook
SUNWELS reported non-consolidated net sales of ¥7,298 million for the three months ended June 30, 2026, up 10.5% year on year, while remaining loss-making with an operating loss of ¥347 million and a net loss of ¥557 million, improving from the previ...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
